Investing.comDoubao · 实盘不做把握 8/10不做原因:无增量信息
北京时间·🕒 发布 20:36:36·⟳ 抓取 20:37:25 +49s·⚡ 决策 10-08 20:38:09 +44s·19.2 天前
Nuwellis宣布将为在研儿童肾脏替代治疗平台Vivian召开医学与护理顾问委员会会议
消息仅宣布一个多月后召开的临床顾问委员会,目的为收集在研产品反馈,不含任何监管批准、订单、商业化数据或业绩指引等硬增量,对股价缺乏可交易的正期望edge。
📄 原文Investing.com↗ 原文
Nuwellis to convene advisory board for pediatric therapy platform
By Investing.com Advertisement Advertisement Nuwellis to convene advisory board for pediatric therapy platform Company…
不做 Nuwellis, Inc.（NUWE.US）
召开在研产品顾问委员会属常规软性公关,无订单、获批、业绩或指引等实质增量,不具备可交易edge;微小市值流动性差,不参与。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
Nuwellis宣布11月为在研儿科平台Vivian召开顾问委员会以收集临床意见,这是研发阶段的常规公关动作,无收入或获批里程碑,不具备短线交易价值,故回避。
🔎 新鲜度:最早出现 2026-10-08 · 扩散 low · price-in 风险 low ↗
主要风险
- Vivian仍处研发早期,顾问委员会反馈存在设计需重大修改的可能,会议本身亦可能无实质产出。
- 公司微小市值、流动性有限,消息驱动的波动易出现冲高回落,追高风险高。
反向证据
- 做多前查反向 · 来源 web · 影响 weakens
微小型医疗科技公司通常存在现金消耗与持续经营风险,且本条无实质利好,做多缺乏支撑。
检索:Nuwellis NUWE cash runway going concern reverse split downgrade 2026
先例如何影响了这次决策
对本次决策的影响:不改变结论;即便存在题材性波动,也因缺乏基本面增量而不做。
方向:无可对照先例,且事件本身无实质催化,无需以先例校准方向。
涨幅量级:无高相似先例;研发期顾问委员会不产生可量化涨幅基准。
形态:未检索到可对照模式。
工具执行结果 · 成功 1 · 降级 0 · 失败 0 · 取消 0
- search_processed_events 成功 stock_tools HTTP · 14 ms
{"result": "search_processed_events:agent query=`nuwe medical nursing advisory board pediatric crrt platform | nuwellis aquadex pediatric 5kg indication expansion | nuwellis vivian pediatric advisory board meeting november 2026`；结构化索引覆盖完整 72 小时；旧记录兼容扫描近 0.0/72 小时、0 条本臂决策(完整)，返回 0 条候选。未命中只表示这些 agent
原文全文
展开原文 · 7,432 字
Nuwellis to convene advisory board for pediatric therapy platform By Investing.com
Advertisement
Advertisement
Nuwellis to convene advisory board for pediatric therapy platform
Company News
Published
Oct 08, 2026, 08:36 AM
Nuwellis to convene advisory board for pediatric therapy platform
View all comments (0)
0
Nuwellis to convene advisory board for pediatric therapy platform
View all comments (0)
0
© Reuters
In this article:
NUWE
-1.43%
MINNEAPOLIS -
Nuwellis
, Inc. (
NASDAQ:NUWE
) announced it will hold a Medical & Nursing Advisory Board meeting on November 18-19, 2026, to support development of Vivian, its pediatric continuous renal replacement therapy platform.
The meeting will bring together approximately a dozen pediatric providers, nurses, and clinical advisors from 11 pediatric institutions across the U.S. for an evaluation of the Vivian System. The platform is under development for children as small as 2.5kg and incorporates multiple fluid management therapies.
According to a press release statement, this marks the company’s first dedicated Vivian Medical & Nursing Advisory Board in several years. The feedback is expected to help validate design decisions, identify clinical and workflow needs, and prioritize future system enhancements.
"Vivian is being purpose-built around the unique clinical and operational needs of pediatric patients and the clinicians who care for them," said Mike McCormick, Nuwellis President and Chief Executive Officer.
The advisory board is part of Nuwellis’ broader pediatric strategy. The company currently markets its Aquadex SmartFlow ultrafiltration system in pediatric hospitals and is working through regulatory procedures to expand the Aquadex indication to pediatric patients weighing 5 kilograms or more. The system’s current minimum labeled patient weight is 20 kilograms.
The Aquadex SmartFlow System is indicated for continuous ultrafiltration therapy for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics.
Nuwellis describes itself as a medical technology company focused on delivering solutions for patients with cardiorenal conditions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Nuwellis to convene advisory board for pediatric therapy platform
View all comments (0)
0
Latest comments
Post
Comment Guidelines
Trade With A Regulated Broker
Indices
Commodities
Bonds
Stocks
US 30
50,815.10
-364.1
-0.71%
US 500
7,769.10
-32.6
-0.42%
Dow Jones
51,179.87
-341.41
-0.66%
S&P 500
7,801.77
-17.16
-0.22%
Nasdaq
27,538.69
-61.19
-0.22%
S&P 500 VIX
15.73
+0.65
+4.31%
Dollar Index
102.105
+0.092
+0.09%
Crude Oil WTI Futures
92.47
+4.19
+4.75%
Brent Oil Futures
104.96
+4.76
+4.75%
Natural Gas Futures
3.266
+0.063
+1.97%
Gold Futures
4,147.30
+6.60
+0.16%
Silver Futures
59.11
-1.184
-1.96%
Copper Futures
6.6308
-0.0187
-0.28%
US Soybeans Futures
1,293.88
-3.12
-0.24%
U.S. 10Y
5.327
+0.049
+0.93%
U.S. 30Y
5.694
+0.033
+0.58%
U.S. 5Y
5.068
+0.047
+0.94%
U.S. 3M
4.151
+0.010
+0.24%
US 10Y T-Note Futures
104.17
-0.31
-0.30%
Euro Bund Futures
120.59
-0.23
-0.19%
10-2 Yield Spread
31.32
+4.15
+15.27%
AAPL
336.67
+3.04
+0.91%
NVDA
237.47
-1.77
-0.74%
GOOGL
350.50
+2.82
+0.81%
TSLA
377.81
-2.87
-0.75%
AMZN
259.92
+3.63
+1.42%
NFLX
69.70
+1.01
+1.47%
META
721.31
-17.57
-2.38%
Advertisement
Most Popular Articles
News
Analysis
Citi names 5 top chip picks ahead of Q3 earnings
By Investing.co
...
Oct 08, 2026
Oil prices surge amid Mideast shipping attacks, U.S. Gulf coast disruptions
By Investing.co
...
Oct 08, 2026
AI debt deal wave reports; Applied Digital reports - what’s moving markets
By Investing.co
...
Oct 08, 2026
Wall Street posts first red session of October a day after notching a record close
By Investing.co
...
Oct 08, 2026
Samsung shares fall as record Q3 profit misses lofty expectations
By Investing.co
...
Oct 08, 2026
Micron Has Surged on the AI Boom - Is It Still a Buy?
By Antonio Rodr
...
Oct 06, 2026
9 Fundamentally Strong Stocks to Watch as Q3 Earnings Get Underway
By David Wagner
Oct 08, 2026
Nvidia Hits Another New High: Key Breakout and Retracement Targets to Watch
By Lee Yang
Oct 06, 2026
Worried Consumers Keep Spending: Here’s Why
By Michael Lebo
...
Oct 07, 2026
Q4 2026 Commodites Forecast: Will Gold and Silver Find a Bottom?
By Jeremy Wagne
...
Oct 07, 2026
More News
Market Movers
Most Active
Gainers %
Losers %
Name
Last
Chg. %
Vol.
MU
1,088.00
+4.06%
30.86M
NVDA
237.47
-0.74%
81.77M
SNDK
1,692.42
+1.92%
9.17M
SPCX
167.60
-2.51%
77.47M
AMD
645.86
-0.55%
18.56M
AAPL
336.67
+0.91%
34.15M
TSLA
377.81
-0.75%
25.59M
Name
Last
Chg. %
Vol.
NRG
108.61
+4.84%
5.39M
MRNA
196.48
+4.81%
14.64M
MU
1,088.00
+4.06%
30.86M
CTVA
14.45
+3.88%
41.33M
VST
166.72
+3.88%
12.01M
SMCI
44.94
+3.41%
40.54M
NTAP
235.77
+3.20%
3.00M
Name
Last
Chg. %
Vol.
MSTR
153.37
-6.79%
21.67M
SKYD
8.89
-6.72%
43.30M
CAT
813.83
-5.75%
3.34M
MHK
119.18
-5.45%
1.70M
NBIS
237.15
-5.09%
18.05M
CRWD
265.44
-4.81%
8.81M
BLDR
53.55
-4.75%
2.36M
Advertisement
Trending Stocks
Name
Last
Chg. %
Vol.
MU
1,088.00
+4.06%
30.86M
SPCX
167.60
-2.51%
77.47M
NVDA
237.47
-0.74%
81.77M
SNDK
1,692.42
+1.92%
9.17M
APLD
23.810
-6.04%
48.76M
Show more
Advertisement
ProPicks AI
AI-powered
stock picks
with a proven track record to
beat the S&P 500
.
Tech Titans
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Top Value Stocks
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Best of Buffett
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Energy Elite
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Financial Fortresses
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Quality Compounders
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Small-Cap Sprinters
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Healthcare Heroes
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Beat the S&P 500
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Dominate the Dow
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Mid-Cap Movers
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Mexican Stock Exchange Leaders
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Best Brazilian Stocks
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Italian Market Elite
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Alpha Germany Select
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Comments
Post
Comment Guidelines
Tools
Calendars
Economic Calendar
Earnings Calendar
Holiday Calendar
US Economy
Fed Rate Monitor Tool
US Treasury Yield Curve
More Tools
Stock Screener
Currency Converter
Markets
Ask WarrenAI
Stocks Picked by AI
Watchlist
Alerts
Top Brokers
Breaking News
Tools
Install Our App
Scan QR code to install app
Follow us
Advertisement
Advertisement
Nuwellis to convene advisory board for pediatric therapy platform
Company News
Published
Oct 08, 2026, 08:36 AM
Nuwellis to convene advisory board for pediatric therapy platform
View all comments (0)
0
Nuwellis to convene advisory board for pediatric therapy platform
View all comments (0)
0
© Reuters
In this article:
NUWE
-1.43%
MINNEAPOLIS -
Nuwellis
, Inc. (
NASDAQ:NUWE
) announced it will hold a Medical & Nursing Advisory Board meeting on November 18-19, 2026, to support development of Vivian, its pediatric continuous renal replacement therapy platform.
The meeting will bring together approximately a dozen pediatric providers, nurses, and clinical advisors from 11 pediatric institutions across the U.S. for an evaluation of the Vivian System. The platform is under development for children as small as 2.5kg and incorporates multiple fluid management therapies.
According to a press release statement, this marks the company’s first dedicated Vivian Medical & Nursing Advisory Board in several years. The feedback is expected to help validate design decisions, identify clinical and workflow needs, and prioritize future system enhancements.
"Vivian is being purpose-built around the unique clinical and operational needs of pediatric patients and the clinicians who care for them," said Mike McCormick, Nuwellis President and Chief Executive Officer.
The advisory board is part of Nuwellis’ broader pediatric strategy. The company currently markets its Aquadex SmartFlow ultrafiltration system in pediatric hospitals and is working through regulatory procedures to expand the Aquadex indication to pediatric patients weighing 5 kilograms or more. The system’s current minimum labeled patient weight is 20 kilograms.
The Aquadex SmartFlow System is indicated for continuous ultrafiltration therapy for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics.
Nuwellis describes itself as a medical technology company focused on delivering solutions for patients with cardiorenal conditions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Nuwellis to convene advisory board for pediatric therapy platform
View all comments (0)
0
Latest comments
Post
Comment Guidelines
Trade With A Regulated Broker
Indices
Commodities
Bonds
Stocks
US 30
50,815.10
-364.1
-0.71%
US 500
7,769.10
-32.6
-0.42%
Dow Jones
51,179.87
-341.41
-0.66%
S&P 500
7,801.77
-17.16
-0.22%
Nasdaq
27,538.69
-61.19
-0.22%
S&P 500 VIX
15.73
+0.65
+4.31%
Dollar Index
102.105
+0.092
+0.09%
Crude Oil WTI Futures
92.47
+4.19
+4.75%
Brent Oil Futures
104.96
+4.76
+4.75%
Natural Gas Futures
3.266
+0.063
+1.97%
Gold Futures
4,147.30
+6.60
+0.16%
Silver Futures
59.11
-1.184
-1.96%
Copper Futures
6.6308
-0.0187
-0.28%
US Soybeans Futures
1,293.88
-3.12
-0.24%
U.S. 10Y
5.327
+0.049
+0.93%
U.S. 30Y
5.694
+0.033
+0.58%
U.S. 5Y
5.068
+0.047
+0.94%
U.S. 3M
4.151
+0.010
+0.24%
US 10Y T-Note Futures
104.17
-0.31
-0.30%
Euro Bund Futures
120.59
-0.23
-0.19%
10-2 Yield Spread
31.32
+4.15
+15.27%
AAPL
336.67
+3.04
+0.91%
NVDA
237.47
-1.77
-0.74%
GOOGL
350.50
+2.82
+0.81%
TSLA
377.81
-2.87
-0.75%
AMZN
259.92
+3.63
+1.42%
NFLX
69.70
+1.01
+1.47%
META
721.31
-17.57
-2.38%
Advertisement
Most Popular Articles
News
Analysis
Citi names 5 top chip picks ahead of Q3 earnings
By Investing.co
...
Oct 08, 2026
Oil prices surge amid Mideast shipping attacks, U.S. Gulf coast disruptions
By Investing.co
...
Oct 08, 2026
AI debt deal wave reports; Applied Digital reports - what’s moving markets
By Investing.co
...
Oct 08, 2026
Wall Street posts first red session of October a day after notching a record close
By Investing.co
...
Oct 08, 2026
Samsung shares fall as record Q3 profit misses lofty expectations
By Investing.co
...
Oct 08, 2026
Micron Has Surged on the AI Boom - Is It Still a Buy?
By Antonio Rodr
...
Oct 06, 2026
9 Fundamentally Strong Stocks to Watch as Q3 Earnings Get Underway
By David Wagner
Oct 08, 2026
Nvidia Hits Another New High: Key Breakout and Retracement Targets to Watch
By Lee Yang
Oct 06, 2026
Worried Consumers Keep Spending: Here’s Why
By Michael Lebo
...
Oct 07, 2026
Q4 2026 Commodites Forecast: Will Gold and Silver Find a Bottom?
By Jeremy Wagne
...
Oct 07, 2026
More News
Market Movers
Most Active
Gainers %
Losers %
Name
Last
Chg. %
Vol.
MU
1,088.00
+4.06%
30.86M
NVDA
237.47
-0.74%
81.77M
SNDK
1,692.42
+1.92%
9.17M
SPCX
167.60
-2.51%
77.47M
AMD
645.86
-0.55%
18.56M
AAPL
336.67
+0.91%
34.15M
TSLA
377.81
-0.75%
25.59M
Name
Last
Chg. %
Vol.
NRG
108.61
+4.84%
5.39M
MRNA
196.48
+4.81%
14.64M
MU
1,088.00
+4.06%
30.86M
CTVA
14.45
+3.88%
41.33M
VST
166.72
+3.88%
12.01M
SMCI
44.94
+3.41%
40.54M
NTAP
235.77
+3.20%
3.00M
Name
Last
Chg. %
Vol.
MSTR
153.37
-6.79%
21.67M
SKYD
8.89
-6.72%
43.30M
CAT
813.83
-5.75%
3.34M
MHK
119.18
-5.45%
1.70M
NBIS
237.15
-5.09%
18.05M
CRWD
265.44
-4.81%
8.81M
BLDR
53.55
-4.75%
2.36M
Advertisement
Trending Stocks
Name
Last
Chg. %
Vol.
MU
1,088.00
+4.06%
30.86M
SPCX
167.60
-2.51%
77.47M
NVDA
237.47
-0.74%
81.77M
SNDK
1,692.42
+1.92%
9.17M
APLD
23.810
-6.04%
48.76M
Show more
Advertisement
ProPicks AI
AI-powered
stock picks
with a proven track record to
beat the S&P 500
.
Tech Titans
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Top Value Stocks
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Best of Buffett
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Energy Elite
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Financial Fortresses
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Quality Compounders
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Small-Cap Sprinters
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Healthcare Heroes
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Beat the S&P 500
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Dominate the Dow
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Mid-Cap Movers
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Mexican Stock Exchange Leaders
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Best Brazilian Stocks
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Italian Market Elite
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Alpha Germany Select
Stocks in this Strategy
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
aaaa aaaaa aaaa a
Unlock Strategy
Comments
Post
Comment Guidelines
Tools
Calendars
Economic Calendar
Earnings Calendar
Holiday Calendar
US Economy
Fed Rate Monitor Tool
US Treasury Yield Curve
More Tools
Stock Screener
Currency Converter
Markets
Ask WarrenAI
Stocks Picked by AI
Watchlist
Alerts
Top Brokers
Breaking News
Tools
Install Our App
Scan QR code to install app
Follow us
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
095d06b06e· 2026-10-08 20:38 · doubao / doubao-seed-evolving-latest-version · 策略包0c89ec5cee9e当前